Heritage Oak Wealth Advisors LLC Buys New Position in Humana Inc. (NYSE:HUM)

Heritage Oak Wealth Advisors LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,248 shares of the insurance provider’s stock, valued at approximately $3,456,000. Humana accounts for about 1.8% of Heritage Oak Wealth Advisors LLC’s holdings, making the stock its 8th biggest position.

Other large investors also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. grew its position in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the period. Hantz Financial Services Inc. bought a new position in Humana in the second quarter worth approximately $35,000. Family Firm Inc. acquired a new stake in Humana in the second quarter valued at approximately $37,000. Hollencrest Capital Management acquired a new stake in Humana in the second quarter valued at approximately $40,000. Finally, Riverview Trust Co acquired a new stake in Humana in the second quarter valued at approximately $44,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. JPMorgan Chase & Co. raised their price objective on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Truist Financial lifted their target price on Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research report on Monday, July 15th. Royal Bank of Canada lifted their target price on Humana from $385.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, September 5th. Oppenheimer lifted their target price on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. Finally, TD Cowen boosted their price objective on Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. Thirteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $398.70.

Humana Price Performance

Humana stock opened at $316.60 on Tuesday. The business has a 50-day simple moving average of $348.57 and a 200 day simple moving average of $344.23. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock has a market cap of $38.15 billion, a price-to-earnings ratio of 19.71, a PEG ratio of 2.44 and a beta of 0.50.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the prior year, the business earned $8.94 EPS. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, research analysts forecast that Humana Inc. will post 16.01 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.